<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Hysterectomy (benign indications): Selection of surgical route</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Hysterectomy (benign indications): Selection of surgical route</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Hysterectomy (benign indications): Selection of surgical route</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark D Walters, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Cecile Ferrando, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Howard T Sharp, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen Eckler, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 01, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H801890402"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>While an open abdominal incision has historically been required for hysterectomy, the surgery has evolved into multiple types of procedures each with its own benefits and limitations. Beyond the traditional abdominal approach, hysterectomy can be performed vaginally or laparoscopically, and the development of robot-assisted systems has added variations for both of these. In addition, routes can be combined.</p><p>This topic review will review the data and clinical issues that impact selection of hysterectomy route. Topics on specific hysterectomy techniques are reviewed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/3308.html" rel="external">"Hysterectomy: Vaginal"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/3286.html" rel="external">"Hysterectomy: Laparoscopic"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/3311.html" rel="external">"Hysterectomy: Abdominal (open) route"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/16554.html" rel="external">"Prophylactic vaginal apex suspension at the time of hysterectomy"</a>.)</p><p></p><p>In this topic, when discussing study results, we will use the terms "woman/en" or "patient(s)" as they are used in the studies presented. We encourage readers to consider the specific counseling and treatment needs of transgender and gender-expansive individuals. </p><p class="headingAnchor" id="H4184839471"><span class="h1">HYSTERECTOMY INDICATIONS AND ALTERNATIVES</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indication for hysterectomy </strong>– There are five broad diagnostic categories of indications for hysterectomy:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Uterine leiomyomas</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Abnormal uterine bleeding</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pelvic organ prolapse (POP)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pelvic pain or infection (eg, endometriosis, pelvic inflammatory diseases)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Malignant and premalignant disease</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment alternatives</strong> – Medical and surgical alternatives to hysterectomy depend upon the underlying disorder. As an example:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Uterine fibroids</strong> – Uterine artery embolization and myomectomy may be used to treat symptomatic leiomyoma [<a href="#rid1">1</a>]. (See  <a class="medical medical_review" href="/d/html/5478.html" rel="external">"Uterine fibroids (leiomyomas): Treatment overview", section on 'Uterine artery embolization'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pelvic organ prolapse</strong> –<strong> </strong>POP can be treated nonsurgically with pelvic floor exercises or pessaries. (See  <a class="medical medical_review" href="/d/html/8081.html" rel="external">"Vaginal pessaries: Indications, devices, and approach to selection"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Chronic pelvic pain</strong> – Pain control interventions, including hormonal therapy such as with contraceptives, may help patients manage intractable pelvic pain (eg, endometriosis) and restore functional status without surgery. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/d/html/7383.html" rel="external">"Endometriosis: Treatment of pelvic pain"</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/d/html/5490.html" rel="external">"Chronic pelvic pain in nonpregnant adult females: Causes"</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/d/html/5435.html" rel="external">"Chronic pelvic pain in adult females: Treatment"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Heavy menstrual bleeding</strong> – Medical therapies, endometrial ablation, and medicated intrauterine devices may be effective therapies for excessive uterine bleeding. (See  <a class="medical medical_review" href="/d/html/5476.html" rel="external">"Abnormal uterine bleeding in nonpregnant reproductive-age patients: Management", section on 'Treatment selection'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Endometriosis</strong> – Medical therapy can help reduce discomfort associated with endometriosis. (See  <a class="medical medical_review" href="/d/html/7383.html" rel="external">"Endometriosis: Treatment of pelvic pain"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Endometrial hyperplasia</strong> –<strong> </strong>Endometrial hyperplasia can sometimes be treated medically with progestins. (See  <a class="medical medical_review" href="/d/html/3217.html" rel="external">"Endometrial hyperplasia: Clinical features, diagnosis, and differential diagnosis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cervical intraepithelial neoplasia </strong>– Conization (eg, cold knife, loop electrosurgical excision procedure) may be adequate therapy for some patients with high grade cervical intraepithelial neoplasia/carcinoma in situ. (See  <a class="medical medical_review" href="/d/html/3215.html" rel="external">"Cervical intraepithelial neoplasia: Management"</a> and  <a class="medical medical_review" href="/d/html/3255.html" rel="external">"Cervical intraepithelial neoplasia: Diagnostic excisional procedures"</a>.)</p><p></p><p class="headingAnchor" id="H2376258961"><span class="h1">ROUTE OF HYSTERECTOMY FOR BENIGN DISEASE</span></p><p class="headingAnchor" id="H1805270992"><span class="h2">Our approach</span><span class="headingEndMark"> — </span>For patients with benign gynecologic disease, we proceed in the order below, as possible based on patient characteristics and preferences  (<a class="graphic graphic_algorithm graphicRef140025" href="/d/graphic/140025.html" rel="external">algorithm 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vaginal route</strong> – Vaginal hysterectomy is the preferred approach for most patients because of its documented advantages and relatively lower complication rates [<a href="#rid2">2-4</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laparoscopic route</strong> – If a vaginal hysterectomy is not feasible because of limited vaginal access, the size of the uterus, or major adhesive disease, then laparoscopic hysterectomy is performed. In some cases, robot-assisted laparoscopy is performed, and the decision to use robotic assistance is usually based on surgeon preference and available resources. Minimally invasive approaches (laparoscopy or robotic-assisted laparoscopy) are preferred to laparotomy because of decreased morbidity and mortality [<a href="#rid5">5</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laparotomy</strong> – Hysterectomy by laparotomy is reserved for all other cases. The supporting data for this approach are described below. (See <a class="local">'Comparison of routes of hysterectomy'</a> below.)</p><p></p><p class="headingAnchor" id="H3978161922"><span class="h2">Trends in surgical route</span><span class="headingEndMark"> — </span>Despite the data and position statements supporting the vaginal approach as the preferred route for hysterectomy, the trend has been toward laparoscopic approaches. A secondary analysis of the United States National Surgical Quality Improvement Program Database that included over 161,000 women undergoing vaginal or laparoscopic hysterectomy reported [<a href="#rid6">6</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Change in distribution of surgical approaches</strong> – Between 2008 and 2018, vaginal hysterectomy rates dropped from 51 to 13 percent while rates for total laparoscopic hysterectomy increased from 12 to 68 percent [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Change in distribution of complications</strong> – Laparoscopic hysterectomy performed in the US between 2008 and 2018 was associated with reduced odds of both major and minor complications compared with vaginal hysterectomy [<a href="#rid6">6</a>]. While this study reported overall complication rates, other data sets have reported increased risk of specific complications (vaginal cuff dehiscence and need for conversion to open abdominal surgery) with laparoscopic hysterectomy compared with vaginal surgery [<a href="#rid7">7</a>]. (See <a class="local">'Vaginal hysterectomy'</a> below.) </p><p></p><p class="bulletIndent1">The review of hysterectomies performed in the US between 2008 and 2018 reported the following major and minor complication rates [<a href="#rid6">6</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Total laparoscopic hysterectomy – Major complications adjusted odds ratio [aOR] 0.813, 95% CI 0.75-0.88 and minor complications aOR 0.72, 95% CI 0.68-0.77.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Laparoscopic-assisted vaginal hysterectomy – Major complications aOR 0.87, 95% CI 0.80-0.96 and minor complications aOR 0.90, 95% CI 0.83-0.96.</p><p></p><p class="headingAnchor" id="H801890425"><span class="h1">COMPARISON OF ROUTES OF HYSTERECTOMY</span><span class="headingEndMark"> — </span>Each surgical route has unique considerations, including time to normal activity, duration of hospitalization, technical feasibility, operating time, and risk of injury. The main body of evidence is from a 2015 meta-analysis of 47 randomized trials, including over 5000 individuals undergoing hysterectomy, comparing abdominal, laparoscopic, and vaginal routes of hysterectomy [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H801890431"><span class="h2">Vaginal hysterectomy</span><span class="headingEndMark"> — </span>Vaginal hysterectomy is the preferred route of hysterectomy, when technically feasible, because it is associated with better outcomes and fewer complications compared with traditional abdominal and total laparoscopic hysterectomy  (<a class="graphic graphic_table graphicRef53367" href="/d/graphic/53367.html" rel="external">table 1</a>) [<a href="#rid3">3,7</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vaginal hysterectomy versus abdominal hysterectomy</strong> [<a href="#rid3">3</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Quicker return to normal activities by approximately 12 days</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Reduction of hospital stay by approximately one day</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vaginal hysterectomy versus total laparoscopic hysterectomy</strong> (ie, the entire surgery is performed laparoscopically):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Vaginal route </strong>– Vaginal hysterectomy is associated with shorter operative time (range of 17 to 42 minutes on average) [<a href="#rid3">3,7</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Laparoscopic route</strong> – When compared with vaginal hysterectomy, a 2017 meta-analysis including 24 articles (trials and observational studies) reported the following for total laparoscopic hysterectomy [<a href="#rid7">7</a>]:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Advantages</strong> – When compared with vaginal hysterectomy, laparoscopy was associated with lower postoperative pain scores on visual analog scale (mean difference [MD] -1.08, 95% CI -1.70 to -0.42), less analgesia use for a shorter period of time (MD -0.64 days, 95% CI -1.06 to -0.22), and reduced length of stay (one versus two days) [<a href="#rid7">7,8</a>]. The clinical significance of the differences in pain outcomes is likely small and the length-of-stay data are from surgeries performed between 2006 and 2015, which may no longer be valid.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Disadvantages</strong> – Compared with vaginal hysterectomy, laparoscopy was associated with higher risks of vaginal cuff dehiscence (odds ratio [OR] 6.3, 95% CI 2.4-16.6) and conversion to laparotomy (OR 3.9, 95% CI 2.2-6.9) [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vaginal robot-assisted surgery</strong> – A robotically-assisted device for vaginal hysterectomy (commercial name Hominis Surgical System) utilizes a single vaginal port with robot-controlled instruments <strong>and</strong> a traditional transabdominal laparoscopic video camera for visualization [<a href="#rid9">9,10</a>]. Comparative data on patients who may benefit from this approach, surgical outcomes, and cost compared with other types of hysterectomy are not yet available. In a pilot observational study of 30 females who underwent vaginal robot-assisted hysterectomy, all procedures were completed as planned without conversion to another route, no intraoperative complications occurred, medial blood loss was 50 mL (range 20-400 mL), and median procedure duration was 57 minutes (range 24-88 minutes) [<a href="#rid11">11</a>]. Pelvic support procedures, such as uterosacral ligament suspension, can be performed as part of vaginal robot-assisted hysterectomy [<a href="#rid12">12</a>].</p><p></p><p class="bulletIndent1">This technology has also been used for other types of transvaginal natural orifice transluminal surgery (vNOTES), including bilateral salpingo-oophorectomy, omentectomy, and vaginal uterosacral ligament suspension [<a href="#rid12">12-15</a>]. This system is a potential alternative for both traditional transabdominal laparoscopy and open abdominal surgery. Proposed benefits compared with traditional laparoscopic surgery include reduced postoperative pain, faster recovery, and improved cosmesis [<a href="#rid16">16</a>].</p><p></p><p class="headingAnchor" id="H13021426"><span class="h2">Laparoscopic hysterectomy</span></p><p class="headingAnchor" id="H1333338931"><span class="h3">Conventional</span><span class="headingEndMark"> — </span>When vaginal hysterectomy is not possible, laparoscopic hysterectomy has several advantages over the abdominal route, but also has a longer operative time and an increased risk of urinary tract injury [<a href="#rid3">3</a>]. However, in comparison with abdominal hysterectomy, a study reported that there was no duration of surgery at which abdominal hysterectomy was associated with reduced morbidity or length of stay compared with laparoscopic hysterectomy, and thus laparoscopic hysterectomy was preferable when possible [<a href="#rid17">17</a>]. (See  <a class="medical medical_review" href="/d/html/3286.html" rel="external">"Hysterectomy: Laparoscopic"</a>.)</p><p class="headingAnchor" id="H3400233241"><span class="h4">Review of data</span><span class="headingEndMark"> — </span>A meta-analysis of 21 randomized trials that compared a variety of laparoscopic hysterectomy techniques (laparoscopic-assisted vaginal hysterectomy, laparoscopic hysterectomy with a vaginal cuff closure, total laparoscopic hysterectomy, single-port laparoscopic hysterectomy, and mini-laparoscopy [defined as port sites not exceeding 3 mm]) with open abdominal surgery reported the following [<a href="#rid3">3</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Improved outcomes</strong> – For laparoscopic hysterectomy compared with abdominal hysterectomy:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Quicker return to normal activities by over 15 days [<a href="#rid3">3</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Shorter hospital admission by one to three days, depending on type of laparoscopic hysterectomy [<a href="#rid3">3,17</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Reduced risk of wound or abdominal wall infection by approximately 70 percent [<a href="#rid3">3</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Lower increased risk of venous thromboembolism with every 60-minute increase in operative time [<a href="#rid18">18</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Worsened outcomes</strong> – For laparoscopic hysterectomy compared with abdominal hysterectomy:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Twofold increased risk of urinary tract (bladder or ureter) injuries [<a href="#rid3">3,19</a>] </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Approximately 30 minute longer operative time</p><p></p><p class="headingAnchor" id="H4150059735"><span class="h4">Patient populations and contraindications</span><span class="headingEndMark"> — </span>Consensus guidelines regarding optimal patient population(s) for laparoscopic hysterectomy are not available. For enlarged uteri, no studies have compared the use of laparoscopic hysterectomy with morcellation, vaginal hysterectomy with morcellation, and open abdominal surgery.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Potential indications</strong> – Laparoscopic hysterectomy is particularly useful in patients with limited vaginal access, a fixed immobile uterus, or who desire supracervical hysterectomy. As the laparoscopic approach provides direct visualization of the intraperitoneal cavity compared with transvaginal surgery, the laparoscopic approach may be particularly helpful for individuals with documented endometriosis, chronic pelvic pain, pelvic adhesive disease (known or suspected), and benign pathology that requires removal (eg, adnexal mass or cyst).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Contraindications</strong> – When planning for laparoscopic hysterectomy, the surgeon must confirm that laparoscopy is technically possible [<a href="#rid2">2</a>]. The American Association of Gynecologic Laparoscopists has defined contraindications to laparoscopic hysterectomy as:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Significant cardiopulmonary disease with intolerance to increased intraperitoneal pressure</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Suspicion of malignancy when morcellation would be required</p><p></p><p class="headingAnchor" id="H2340798705"><span class="h3">Robot-assisted laparoscopy</span><span class="headingEndMark"> — </span>Robot-assisted laparoscopy, a variation on the conventional laparoscopic technique, has been used for hysterectomy but has not been reported to improve surgical outcomes compared with traditional laparoscopy [<a href="#rid3">3,20-28</a>]. As such, conventional laparoscopic hysterectomy is preferred to robot-assisted hysterectomy when the vaginal approach is not feasible.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Potential benefits</strong> – As robot-assisted laparoscopy provides improved visualization with three-dimensional imaging, better mechanics, improved ergonomics, and an easier and faster learning curve for many surgeons, and has similar outcomes compared with traditional laparoscopy, it may be helpful for avoiding open abdominal hysterectomy or in select populations, such as the very obese or those with severe pelvic adhesive disease [<a href="#rid27">27,29-31</a>]. Subgroups of patients who clearly benefit from the robot-assisted approach to hysterectomy have not yet been defined [<a href="#rid31">31</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Disadvantages</strong> – Disadvantages include the need for additional surgical training, loss of haptic feedback, and cost. In addition to the cost of the system, the surgical instruments that attach to the robotic arms must be replaced after every 10 uses. (See  <a class="medical medical_review" href="/d/html/3297.html" rel="external">"Robot-assisted laparoscopy", section on 'Robot-assisted versus other surgical approaches'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Outcomes</strong> – Surgical outcomes are similar for traditional laparoscopy and robot-assisted laparoscopy when used for hysterectomy [<a href="#rid3">3,20-24,27</a>]. When comparisons are made between robot-assisted laparoscopic hysterectomy and open abdominal hysterectomy, the open approach may be associated with a higher incidence of complications [<a href="#rid27">27</a>].</p><p></p><p class="headingAnchor" id="H1893071005"><span class="h3">Single-port</span><span class="headingEndMark"> — </span>While traditional laparoscopic hysterectomy remains the technique of choice if vaginal hysterectomy is not feasible, single-port laparoscopy is a variant of the conventional laparoscopic technique. Compared with traditional laparoscopy for hysterectomy, single-port surgery can be more technically challenging to perform. One potential advantage is that similar instrumentation can also be used transvaginally to accomplish "natural orifice" transvaginal hysterectomy [<a href="#rid32">32</a>]. (See <a class="local">'Vaginal hysterectomy'</a> above.)</p><p>Compared with traditional laparoscopy, studies of the single-port laparoscopy have reported:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Surgical outcomes</strong> – A 2015 meta-analysis of randomized trials found that single-port laparoscopy offered no advantages over traditional laparoscopic techniques [<a href="#rid3">3</a>]. Continued development and use of single-port systems may identify patient groups who benefit from this approach. As the operative outcomes are not worse for single-port laparoscopy compared with traditional laparoscopy, single-port laparoscopy is an option for individuals who prioritize a single incision for cosmesis or other reasons. (See  <a class="medical medical_review" href="/d/html/15103.html" rel="external">"Abdominal access techniques used in laparoscopic surgery", section on 'Single-incision laparoscopic surgery'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Possible reduction in postoperative pain</strong> – A randomized trial comparing single-port with traditional laparoscopic hysterectomy reported that single-port surgery was associated with reduced pain scores at 24 and 48 hours and lower narcotic use, but it is not known if these differences were clinically important [<a href="#rid33">33</a>].</p><p></p><p class="headingAnchor" id="H801890449"><span class="h2">Abdominal hysterectomy</span><span class="headingEndMark"> — </span>Abdominal hysterectomy is the default procedure when vaginal or laparoscopic hysterectomy cannot manage the patient's clinical situation or when facilities cannot support a specific procedure [<a href="#rid2">2,4</a>]. (See  <a class="medical medical_review" href="/d/html/3311.html" rel="external">"Hysterectomy: Abdominal (open) route"</a>.)</p><p class="headingAnchor" id="H801890461"><span class="h1">FACTORS THAT INFLUENCE SURGICAL ROUTE</span><span class="headingEndMark"> — </span>Characteristics proposed as selection criteria for determining the feasibility of a minimally invasive hysterectomy include uterine size, mobility, accessibility, and uterine pathology (not including adnexal pathology or suspected adhesions)  (<a class="graphic graphic_algorithm graphicRef140025" href="/d/graphic/140025.html" rel="external">algorithm 1</a>) [<a href="#rid34">34-36</a>].</p><p class="headingAnchor" id="H2288999013"><span class="h2">Uterus size, shape, and accessibility</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Uterus size </strong>– Although the upper limit of uterine size for vaginal hysterectomy has not been established, many surgeons would consider 16-week size as a reasonable and practical upper limit [<a href="#rid37">37</a>]. When vaginal access is adequate and the uterus is enlarged, vaginal hysterectomy is accomplished using uterine size reduction techniques such as wedge morcellation, uterine bisection, and intramyometrial coring.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Vaginal versus abdominal routes</strong> – A randomized trial comparing vaginal and abdominal hysterectomy for 119 women with enlarged uteri (200 to 1300 grams) reported decreased operating time, febrile morbidity, postoperative narcotic use, and hospital stay for the vaginal hysterectomy group [<a href="#rid38">38</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Vaginal versus laparoscopic routes</strong> – A retrospective cohort study comparing vaginal (n = 1870) with laparoscopic (n = 3740) total hysterectomy for patients with enlarged uteri (weight &gt;250 grams) reported similar major complication rates between the groups (4.3 versus 5.3, respectively) [<a href="#rid39">39</a>]. Intraoperative cystotomies were more common with vaginal surgery while ureteral injuries were more common with laparoscopic surgery (cystotomy 0.8 versus 0.3 percent, ureteral injury 0.2 versus 1.2 percent), which is consistent with those surgical approaches. Vaginal surgery was associated with a lower probability of operating time exceeding 2.5 hours.</p><p></p><p class="bulletIndent1">For experienced surgeons, uterus size is less of a barrier for minimally invasive hysterectomy. While uterus weight is an independent risk factor for posthysterectomy complications, abdominal hysterectomy has higher odds of any complication compared with laparoscopic hysterectomy, even in women with markedly enlarged uteri [<a href="#rid40">40</a>]. Uterine weight alone is not an appropriate indication for abdominal hysterectomy as large uteri can be safely removed laparoscopically.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Uterus shape</strong> – We believe uterus shape is often more important than actual size in considering vaginal hysterectomy. Before beginning any morcellation procedure, the uterine vessels are ligated bilaterally, and the peritoneal cavity is entered both anteriorly and posteriorly. If the cervix or lower uterine segment is enlarged or contains fibroids that prevent uterine artery ligation or entry into the peritoneal cavity, then the procedure is not performed vaginally. In contrast, if the lower uterine segment is accessible surgically, then even very large uteri (up to 20-week size) can be removed transvaginally by an appropriately skilled surgeon.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Accessibility of the uterus</strong> – If the vaginal aperture is adequate to allow division of the uterosacral and cardinal ligaments, uterine mobility is often adequate to allow completion of vaginal hysterectomy, even if there is minimal uterine descent [<a href="#rid41">41</a>]. Historically, a narrow pubic arch (less than 90 degrees), a narrow vagina, an undescended immobile uterus, and nulliparity were proposed as contraindications for vaginal hysterectomy, but this thinking no longer applies. In a retrospective review of 300 individuals without prior vaginal delivery who underwent hysterectomy, 92 percent of the planned vaginal hysterectomies were completed by the vaginal route [<a href="#rid42">42</a>]. Of note, nearly 76 percent of cases were planned as vaginal hysterectomies.</p><p></p><p class="headingAnchor" id="H1994910110"><span class="h2">Additional pathology or need for abdominal exploration</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Extrauterine pathology</strong> – Disease outside the uterus, such as adnexal pathology, obliterated cul-de-sac, endometriosis, or pelvic adhesions, may prevent vaginal hysterectomy. Laparoscopy can be useful in these cases to visualize pelvic anatomy and pathology and directly inform the choice of hysterectomy route. In a study of 46 individuals who had been advised to have an abdominal hysterectomy, findings at intraoperative laparoscopy allowed 91 percent of the patients to have a vaginal hysterectomy [<a href="#rid43">43</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Need to evaluate the intrabdominal cavity</strong> – Vaginal hysterectomy does not allow thorough examination of the abdomen. When this is required, a laparoscopic approach is appropriate. (See  <a class="medical medical_review" href="/d/html/3286.html" rel="external">"Hysterectomy: Laparoscopic"</a>.)</p><p></p><p class="headingAnchor" id="H1456987309"><span class="h2">Patient characteristics</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prior cesarean delivery or pelvic surgery</strong> – While a history of previous pelvic surgery raises concerns about lower uterine segment scarring, resultant bladder trauma, excessive bleeding, and potential unsuccessful vaginal route, prior cesarean delivery is not a contraindication to vaginal hysterectomy. Surgical risk, particularly for blood transfusion, may be increased with increasing number of cesarean deliveries, but overall risk of severe surgical complications does not appear to be increased. Supporting data include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A registry-based cohort study from Denmark (n = 7685 individuals) reported the peri- and postoperative complications at hysterectomy were more frequent in patients with previous cesarean deliveries, with adjusted odds ratios (aORs) of 1.16 (95% CI 0.98-1.37) for one cesarean delivery and 1.30 (95% CI 1.02-1.65) for two or more cesarean deliveries [<a href="#rid44">44</a>]. Administration of blood transfusion was almost twice as frequent after two or more cesarean deliveries.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A retrospective review of 742 vaginal hysterectomies performed at an academic medical center also noted prior cesarean delivery increased the risk of blood transfusion at the time of vaginal hysterectomy but reported similar rates of grades 2 to 3 Clavien-Dindo complications among patients with and without prior cesarean delivery  (<a class="graphic graphic_table graphicRef110852" href="/d/graphic/110852.html" rel="external">table 2</a>) [<a href="#rid45">45</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nulliparity</strong> – Nulliparity is not a contraindication to vaginal hysterectomy; patients who are nulliparous or who have not delivered vaginally can safely undergo vaginal hysterectomy [<a href="#rid42">42</a>]. A prospective study comparing vaginal hysterectomy outcomes in 52 nulliparous and 293 primiparous or multiparous women reported nulliparity was associated with longer mean operative times (95 versus 80 minutes), higher overall complication rates (13 versus 4 percent), and increased hemorrhage rates (7.7 versus 1.7 percent) [<a href="#rid46">46</a>]. Nevertheless, vaginal hysterectomy was successfully performed in 50 of the 52 nulliparous and 292 of the 293 parous patients. This suggests that nulliparous women are candidates for vaginal hysterectomy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Obesity</strong> – Obesity is not a contraindication to vaginal hysterectomy and thus is the preferred route for hysterectomy if other criteria for vaginal surgery are met [<a href="#rid47">47-49</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Compared with laparoscopy</strong> – Laparoscopic hysterectomy is selected when the vaginal route is not possible; complication rates are similar for patients with and without obesity who undergo laparoscopic hysterectomy [<a href="#rid50">50</a>]. For individuals with obesity who undergo laparoscopic or robot-assisted laparoscopic hysterectomy, the risk of conversion to open surgery appears to be increased and in proportion to the degree of obesity [<a href="#rid51">51,52</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Compared with open abdominal surgery</strong> – Abdominal hysterectomy in patients with obesity has been reported as having a five times higher risk of wound dehiscence, five times higher risk of wound infection, and 89 percent increased risk of sepsis as compared with abdominal hysterectomy in patients with normal body mass index [<a href="#rid53">53</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patient preoperative ASA classification</strong>–<strong> </strong>In a National Surgical Quality Improvement Program database study, 117,919 patients who underwent either minimally invasive hysterectomy (vaginal, laparoscopic, robotic) or abdominal hysterectomy were compared. Patients with increased preoperative risk as defined by a high ASA classification were less likely to undergo a hysterectomy using a minimally invasive route for benign indications.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patient preference</strong> – An informed patient may have a preference for the hysterectomy route. After consideration of the advantages and disadvantages of each type of hysterectomy, the surgeon can then include the patient in the discussion and arrive at the optimal surgical route for her disease and circumstances.</p><p></p><p class="headingAnchor" id="H2575849022"><span class="h2">Need for additional procedures or supracervical hysterectomy</span></p><p class="headingAnchor" id="H1094214628"><span class="h3">Prophylactic oophorectomy or salpingectomy</span><span class="headingEndMark"> — </span>Briefly, the decision to perform prophylactic oophorectomy and/or salpingectomy at hysterectomy is based on patient preference, age, and medical risk factors [<a href="#rid54">54</a>]. The use of laparoscopic-assisted vaginal hysterectomy or total laparoscopic hysterectomy purely to facilitate tubal or ovarian removal is not supported by convincing evidence [<a href="#rid55">55,56</a>]. From a practical perspective, the rate of prophylactic oophorectomy is 4 to 12 times higher with abdominal or laparoscopic routes compared with vaginal surgery, which may reflect challenges inherent in performing oophorectomy by the vaginal route (eg, an ovary that is scarred to the pelvic sidewall and cannot be mobilized or a short infundibulopelvic ligament both limit surgical access to the ovary), reduced surgeon experience with vaginal oophorectomy, or patient preferences [<a href="#rid57">57,58</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vaginal salpingo-oophorectomy success rates </strong>– In a study of 258 patients undergoing vaginal hysterectomy, although 56 percent had at least one relative contraindication to concurrent salpingo-oophorectomy, successful removal was achieved in 87 percent of patients [<a href="#rid59">59</a>]. Thus, patients who are candidates for vaginal hysterectomy and who desire prophylactic oophorectomy based on their risk profile are counseled that vaginal oophorectomy is possible in a majority of cases but that laparoscopy or minilaparotomy may be necessary to complete the oophorectomy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Relative contraindications to vaginal salpingo-oophorectomy</strong> – Relative contraindications to concurrent salpingectomy or oophorectomy at the time of vaginal hysterectomy may include lack of pelvic organ descent, an enlarged uterus, previous cesarean delivery, known pelvic adhesions, and known adnexal pathologic conditions.</p><p></p><p>The risks and benefits of elective oophorectomy and/or salpingectomy at the time of hysterectomy are discussed in detail elsewhere.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/14198.html" rel="external">"Elective oophorectomy or ovarian conservation at the time of hysterectomy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/3250.html" rel="external">"Risk-reducing salpingo-oophorectomy in patients at high risk of epithelial ovarian and fallopian tube cancer"</a>.)</p><p></p><p class="headingAnchor" id="H395553852"><span class="h3">Pelvic organ prolapse</span><span class="headingEndMark"> — </span>Hysterectomy is often performed at the time of surgical repair of pelvic organ prolapse (POP). However, this varies in part by surgical route (vaginal or abdominal) and use of synthetic materials for repair. (See  <a class="medical medical_review" href="/d/html/14212.html" rel="external">"Pelvic organ prolapse in women: Choosing a primary surgical procedure", section on 'Concomitant hysterectomy'</a>.)</p><p class="headingAnchor" id="H2615631882"><span class="h3">Supracervical (subtotal) hysterectomy</span><span class="headingEndMark"> — </span>In general, the decision to remove the cervix with the uterine corpus (ie, total hysterectomy) or just the corpus (ie, supracervical or subtotal hysterectomy) is mainly driven by patient preference to retain the cervix. The only absolute contraindication to supracervical (subtotal) hysterectomy is malignant or premalignant condition of the uterine corpus or cervix. The potential advantage of shorter operative time with supracervical hysterectomy is small (about 11 minutes for open abdominal surgery) and must be balanced against the potential need for future treatment of cervical cancer (0.05 to 0.27 percent) or cervical bleeding [<a href="#rid60">60</a>]. (See  <a class="medical medical_review" href="/d/html/134395.html" rel="external">"Hysterectomy (benign indications): Patient-important issues and surgical complications", section on 'Risk of occult malignancy'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Comparison of surgical outcomes for supracervical and total hysterectomy</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A 2012 systematic review of nine randomized trials (n = 1553) comparing total versus supracervical hysterectomy found no difference between groups in major outcomes such as urinary, bowel, or sexual function; recovery from surgery; complications; readmission rate; and transfusion [<a href="#rid61">61</a>]. Major disadvantages of the supracervical procedure were continued need for cancer screening and cyclic vaginal bleeding, which occurred in 7 to 20 percent of patients with supracervical hysterectomy compared with 1 to 3 percent of patients with total hysterectomy. In addition, approximately 2 percent of patients subsequently needed trachelectomy. The patients in these trials were followed from two to nine years.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A subsequent study of individuals from a previous randomized trial reported on outcomes 14 years after surgery. Similarly, there were no differences in urinary incontinence, POP, and prolapse symptoms between women undergoing supracervical or total hysterectomy [<a href="#rid62">62</a>]. One hundred of the original 304 women from the original trial participated in the follow-up study.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients who may benefit from supracervical hysterectomy</strong> – Circumstances in which supracervical hysterectomy is performed include before some types of sacrocolpopexy and for patients who prefer this option for personal or sexual reasons. However, data regarding the impact of total versus supracervical hysterectomy on sexual function are mixed, in part because of different indications for the procedures, impact of concomitant oophorectomy, varying outcomes measured, and use of retrospective data with small numbers of included patients [<a href="#rid63">63-66</a>]. While a patient may prefer supracervical hysterectomy, the data do not suggest improved sexual function with retention of the cervix. (See  <a class="medical medical_review" href="/d/html/8073.html" rel="external">"Pelvic organ prolapse in women: Surgical repair of apical prolapse (uterine or vaginal vault prolapse)", section on 'Abdominal sacrocolpopexy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients who may benefit from total hysterectomy</strong> – While not absolute contraindications to supracervical hysterectomy, individuals with endometriosis and chronic pain syndromes may benefit from total removal of the uterus. However, more data are needed before definitive recommendations can be made.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Endometriosis </strong>– Supracervical hysterectomy performed for endometriosis, but not adenomyosis, has been associated with increased risk of future trachelectomy [<a href="#rid67">67,68</a>]. In a retrospective case-control study of 17 women who underwent supracervical hysterectomy, women with a history of endometriosis had an approximately sixfold increased risk of subsequent trachelectomy compared with those without [<a href="#rid67">67</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Chronic pain syndromes</strong> – In a retrospective cohort study of cervix specimens from 35 individuals, cervices from those with pain syndromes had more nerve fibers per high power field than cervices of those without pain or control women, a trend which was also seen in patients with endometriosis [<a href="#rid69">69</a>]. This small study provides indirect data that total hysterectomy may be beneficial in individuals with chronic pelvic pain as their indication for hysterectomy.</p><p></p><p class="headingAnchor" id="H3929521878"><span class="h2">Use of a surgical decision support tool</span><span class="headingEndMark"> — </span>Given improved patient outcomes with vaginal hysterectomy compared with other routes, decision support tools have been developed to encourage surgeons to pursue vaginal surgery as their first-line route and then guide them to other approaches based on specific criteria. Supporting data include:</p><p class="bulletIndent1"><span class="glyph">●</span>One United States academic center reported that use of a decision-tree algorithm triaged the majority of patients to total vaginal hysterectomy (71 percent) and more than 99 percent of the total attempted vaginal hysterectomies were completed by that route [<a href="#rid70">70</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Selection of surgical route was primarily based on uterus size, mobility, and location, as well as vaginal caliber and prior pelvic surgery.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Exclusion criteria for vaginal surgery included adnexal disease, planned-for additional incontinence or prolapse procedures (other than pure uterine), cervical cancer beyond stage 1A1, uterine or müllerian anomalies, and malignancy (confirmed or suspected).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a South African academic medical center, implementation of a clinical decision-tree algorithm and standardized surgical technique increased rates of vaginal hysterectomy (from 9.8 percent to 48.2 percent) and reduced rates of abdominal hysterectomy (from 91.2 to 51.6 percent) [<a href="#rid71">71</a>]. The ratio of vaginal hysterectomy to abdominal hysterectomy increased from 1:9 in 2001 to 1:1 by 2014. None of the vaginal surgeries required conversion to an abdominal route.</p><p></p><p class="headingAnchor" id="H4175046564"><span class="h2">Surgeon volume</span><span class="headingEndMark"> — </span>Surgeon volume is inversely related to patient outcomes and complication rates [<a href="#rid72">72-77</a>]. Experienced high-volume surgeons at high-volume hospitals have less blood loss, fewer adverse events, and lower costs. In addition, high-volume surgeons are more likely to use minimally invasive routes of hysterectomy [<a href="#rid75">75</a>].</p><p class="headingAnchor" id="H1906562484"><span class="h2">Cost considerations</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>By surgical route</strong> – Cost-analysis trials consistently demonstrate that vaginal hysterectomy is the most cost-effective route [<a href="#rid78">78-80</a>] and robot-assisted hysterectomy is the least cost-effective route [<a href="#rid80">80,81</a>]. Laparoscopic hysterectomy can be cost-effective relative to abdominal procedure [<a href="#rid82">82</a>], but the difference varies among surgeons, health systems, countries, and viewpoints (societal versus institutional) [<a href="#rid79">79,83</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Drivers of cost</strong> – The main cost determinants are the length of hospital stay, the length of operating room time, and the use of disposable surgical devices [<a href="#rid78">78</a>]. Local initiatives and cost-awareness campaigns may be associated with reduction in cost of surgery for laparoscopic hysterectomy [<a href="#rid84">84</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Robot-assisted procedures</strong> – Some experts have stated that, based on the available data, a scenario in which robot-assisted hysterectomy is cost-effective is unlikely [<a href="#rid81">81</a>]. One challenge to assessing cost-effectiveness is that cost can be calculated as the cost of all the equipment (including the purchase of the robot system) or as the cost of equipment used per case (ie, assume the robot system is a preexisting investment). In general, robot-assisted laparoscopic hysterectomy is more costly than conventional laparoscopic technique [<a href="#rid20">20-22,85,86</a>]. (See  <a class="medical medical_review" href="/d/html/3297.html" rel="external">"Robot-assisted laparoscopy", section on 'Are surgical robots cost-effective?'</a>.)</p><p></p><p class="headingAnchor" id="H3942014032"><span class="h1">ADDITIONAL SURGICAL PLANNING</span><span class="headingEndMark"> — </span>An overview of issues pertaining to preoperative preparation and assessment, including antibiotic administration and prevent of thromboembolic events, can be found separately. (See  <a class="medical medical_review" href="/d/html/3301.html" rel="external">"Overview of preoperative evaluation and preparation for gynecologic surgery"</a>.)</p><p class="headingAnchor" id="H1090581448"><span class="h2">Enhanced recovery after surgery</span><span class="headingEndMark"> — </span>Enhanced recovery after surgery (ERAS) programs are perioperative protocols of evidence-based interventions that have been grouped together with the goals of speeding functional recovery and improving postoperative outcomes. ERAS programs typically include multidisciplinary and multimodal interventions aimed at minimizing the physiologic changes associated with surgery. Patient benefits associated with ERAS include reduction in postoperative opioid use and length of stay. (See  <a class="medical medical_review" href="/d/html/113714.html" rel="external">"Enhanced recovery after gynecologic surgery: Components and implementation"</a>.)</p><p class="headingAnchor" id="H833729420"><span class="h2">Patient education</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rationale for hysterectomy</strong> – The reason for the hysterectomy, risks and benefits of the procedure, alternatives, and expectations for outcome should be discussed with the patient in detail. Since a number of the indications for hysterectomy are based more upon opinion than evidence from well-designed studies, informed consent with thorough exploration of patient preferences and expectations is particularly important [<a href="#rid87">87</a>]. In the absence of a life-threatening emergency (eg, uterine hemorrhage), the decision to proceed with hysterectomy is made mutually by the patient and her clinician based upon her functional impairment, childbearing plans, response to medical therapy, discussion of alternatives, and perception that the risks of the procedure are outweighed by the expected benefits.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postoperative</strong> <strong>expectations</strong> – Patients should be provided with clear information about what to expect during their hospitalization and regarding return to normal activities. Education during the preoperative office visits will enhance the patient's acceptance and compliance during the immediate postoperative period and may help to shorten hospital stay.</p><p></p><p class="headingAnchor" id="H2275895803"><span class="h2">Informed consent</span><span class="headingEndMark"> — </span>Informed consent for route of hysterectomy is a process. The route and type of hysterectomy is discussed in detail, including the advantages and disadvantages of each option and the surgeon's recommendation. The reason for the hysterectomy, risks and benefits of the procedure, alternatives, and expectations for outcome are discussed. Issues regarding total versus supracervical (subtotal) hysterectomy, and whether adnexal surgery is indicated, are discussed. Risk of occult malignancy that may require further surgical or medical therapy is included on the consent form. The possibility of conversion from a laparoscopic or vaginal approach to laparotomy, if necessary, is also reviewed.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/15076.html" rel="external">"Informed procedural consent", section on 'Informed decision-making'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/3301.html" rel="external">"Overview of preoperative evaluation and preparation for gynecologic surgery", section on 'Informed consent and patient expectations'</a>.)</p><p></p><p class="headingAnchor" id="H801890541"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Summary</strong> – For individuals with benign gynecologic disease undergoing hysterectomy, vaginal hysterectomy is the preferred approach when technically possible because of its documented advantages and relatively lower complication rates  (<a class="graphic graphic_algorithm graphicRef140025" href="/d/graphic/140025.html" rel="external">algorithm 1</a>). If a vaginal hysterectomy is not feasible, then laparoscopic hysterectomy is performed. Laparoscopy is preferred to laparotomy because of decreased morbidity and mortality. Hysterectomy by laparotomy is reserved for all other cases. The role of robot-assisted laparoscopy for hysterectomy is under evaluation. This approach is in accord with national and international groups. (See <a class="local">'Route of hysterectomy for benign disease'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Vaginal approach preferred when possible</strong> – For individuals in whom all routes of hysterectomy are technically feasible, we recommend a vaginal approach (<a class="grade" href="https://medilib.ir/uptodate/show/grade_2" rel="external">Grade 1B</a>). Compared with other routes of hysterectomy, it is less invasive, more cosmetic, and associated with fewer complications, shorter hospital admission, and lower cost. Individuals who have larger uteri, adnexal pathology, extrauterine disease, advanced endometriosis, or who desire definitive oophorectomy may require laparoscopic assistance at hysterectomy to complete the surgery. (See <a class="local">'Vaginal hysterectomy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Laparoscopy if vaginal surgery not feasible</strong> – For individuals in whom vaginal hysterectomy is contraindicated or not technically possible, we suggest conventional laparoscopic hysterectomy rather than abdominal hysterectomy (<a class="grade" href="https://medilib.ir/uptodate/show/grade_5" rel="external">Grade 2B</a>). Robot-assisted laparoscopy and single-port laparoscopy do not have improved outcomes compared with conventional laparoscopy but may be considered in select cases. (See <a class="local">'Laparoscopic hysterectomy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Total rather than supracervical hysterectomy</strong> – For individuals undergoing hysterectomy, we suggest performing total hysterectomy rather than supracervical hysterectomy (<a class="grade" href="https://medilib.ir/uptodate/show/grade_5" rel="external">Grade 2B</a>). There are no proven medical or surgical benefits of performing supracervical (subtotal) hysterectomy if the cervix can be easily removed with the corpus. However, some individuals may choose this option after appropriate counseling of its benefits and risks. Those who retain their cervix continue with cervical cancer screening according to guidelines. (See <a class="local">'Supracervical (subtotal) hysterectomy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Additional surgical factors for consideration</strong> – Additional factors that influence the route of hysterectomy for benign indications include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Surgical indications and patient factors</strong> – Selection of surgical approach for hysterectomy for benign disease is impacted by the surgical indications and related issues of uterine size and pathology, pelvic anatomy, and vaginal access. In general, factors such as prior cesarean delivery, nulliparity, and obesity do not influence the route of hysterectomy.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>(See <a class="local">'Uterus size, shape, and accessibility'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>(See <a class="local">'Patient characteristics'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Potential pathology and/or need for additional surgery</strong> – Potential presence of uterine pathology, need for abdominal exploration, or need for additional surgery may increase the benefits of one approach over the others. (See <a class="local">'Additional pathology or need for abdominal exploration'</a> above and <a class="local">'Need for additional procedures or supracervical hysterectomy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Additional surgical planning</strong> – Additional considerations include protocols for enhanced recovery after surgery (ERAS), patient education, and informed consent. (See <a class="local">'Additional surgical planning'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Falcone T, Parker WH. Surgical management of leiomyomas for fertility or uterine preservation. Obstet Gynecol 2013; 121:856.</a></li><li><a class="nounderline abstract_t">AAGL Advancing Minimally Invasive Gynecology Worldwide. AAGL position statement: route of hysterectomy to treat benign uterine disease. J Minim Invasive Gynecol 2011; 18:1.</a></li><li><a class="nounderline abstract_t">Aarts JW, Nieboer TE, Johnson N, et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev 2015; :CD003677.</a></li><li><a class="nounderline abstract_t">Committee Opinion No 701: Choosing the Route of Hysterectomy for Benign Disease. Obstet Gynecol 2017; 129:e155.</a></li><li class="breakAll">FIGO Statement. Minimal Access Gynecological Surgery. International Federation of Gynecology and Obstetrics. March 2020. https://www.figo.org/minimal-access-gynecological-surgery (Accessed on April 09, 2021).</li><li><a class="nounderline abstract_t">Luchristt D, Brown O, Kenton K, Bretschneider CE. Trends in operative time and outcomes in minimally invasive hysterectomy from 2008 to 2018. Am J Obstet Gynecol 2021; 224:202.e1.</a></li><li><a class="nounderline abstract_t">Sandberg EM, Twijnstra AR, Driessen SR, Jansen FW. Total Laparoscopic Hysterectomy Versus Vaginal Hysterectomy: A Systematic Review and Meta-Analysis. J Minim Invasive Gynecol 2017; 24:206.</a></li><li><a class="nounderline abstract_t">Agrawal S, Chen L, Tergas AI, et al. Characteristics associated with prolonged length of stay after hysterectomy for benign gynecologic conditions. Am J Obstet Gynecol 2018; 219:89.e1.</a></li><li class="breakAll">FDA Authorizes First Robotically-Assisted Surgical Device for Performing Transvaginal Hysterectomy. FDA News Release. US Food and Drug Administration. March 2021. https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-robotically-assisted-surgical-device-performing-transvaginal-hysterectomy (Accessed on April 07, 2021).</li><li class="breakAll">Hominis Robot-Assisted Surgical Platform. Memic Innovative Surgery. 2021. https://www.memicmed.com/hominis/ (Accessed on April 07, 2021).</li><li><a class="nounderline abstract_t">Lowenstein L, Mor O, Matanes E, et al. Robotic Vaginal Natural Orifice Transluminal Endoscopic Hysterectomy for Benign Indications. J Minim Invasive Gynecol 2021; 28:1101.</a></li><li><a class="nounderline abstract_t">Aharoni S, Matanes E, Lauterbach R, et al. Transvaginal natural orifice transluminal endoscopic versus conventional vaginal hysterectomy with uterosacral ligament suspension for apical compartment prolapse. Eur J Obstet Gynecol Reprod Biol 2021; 260:203.</a></li><li><a class="nounderline abstract_t">Lowenstein L, Matanes E, Lauterbach R, et al. Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) for omentectomy - A case series. Surg Oncol 2020; 34:186.</a></li><li><a class="nounderline abstract_t">Lowenstein L, Matanes E, Weiner Z, Baekelandt J. Robotic transvaginal natural orifice transluminal endoscopic surgery for bilateral salpingo oophorectomy. Eur J Obstet Gynecol Reprod Biol X 2020; 7:100113.</a></li><li><a class="nounderline abstract_t">Lowenstein L, Baekelandt J, Paz Y, et al. Transvaginal Natural Orifice Transluminal Endoscopic Hysterectomy and Apical Suspension of the Vaginal Cuff to the Uterosacral Ligament. J Minim Invasive Gynecol 2019; 26:1015.</a></li><li><a class="nounderline abstract_t">Baekelandt J, De Mulder PA, Le Roy I, et al. Postoperative outcomes and quality of life following hysterectomy by natural orifice transluminal endoscopic surgery (NOTES) compared to laparoscopy in women with a non-prolapsed uterus and benign gynaecological disease: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2017; 208:6.</a></li><li><a class="nounderline abstract_t">Chakraborty N, Rhodes S, Luchristt D, et al. Is Total Laparoscopic Hysterectomy with Longer Operative Time Associated with a Decreased Benefit Compared to total Abdominal Hysterectomy? Am J Obstet Gynecol 2022.</a></li><li><a class="nounderline abstract_t">Moulder JK, Moore KJ, Strassle PD, Louie M. Effect of length of surgery on the incidence of venous thromboembolism after benign hysterectomy. Am J Obstet Gynecol 2021; 224:364.e1.</a></li><li><a class="nounderline abstract_t">Chang EJ, Mandelbaum RS, Nusbaum DJ, et al. Vesicoureteral Injury during Benign Hysterectomy: Minimally Invasive Laparoscopic Surgery versus Laparotomy. J Minim Invasive Gynecol 2020; 27:1354.</a></li><li><a class="nounderline abstract_t">Paraiso MF, Ridgeway B, Park AJ, et al. A randomized trial comparing conventional and robotically assisted total laparoscopic hysterectomy. Am J Obstet Gynecol 2013; 208:368.e1.</a></li><li><a class="nounderline abstract_t">Wright JD, Ananth CV, Lewin SN, et al. Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease. JAMA 2013; 309:689.</a></li><li><a class="nounderline abstract_t">Pasic RP, Rizzo JA, Fang H, et al. Comparing robot-assisted with conventional laparoscopic hysterectomy: impact on cost and clinical outcomes. J Minim Invasive Gynecol 2010; 17:730.</a></li><li><a class="nounderline abstract_t">Reza M, Maeso S, Blasco JA, Andradas E. Meta-analysis of observational studies on the safety and effectiveness of robotic gynaecological surgery. Br J Surg 2010; 97:1772.</a></li><li><a class="nounderline abstract_t">Albright BB, Witte T, Tofte AN, et al. Robotic Versus Laparoscopic Hysterectomy for Benign Disease: A Systematic Review and Meta-Analysis of Randomized Trials. J Minim Invasive Gynecol 2016; 23:18.</a></li><li><a class="nounderline abstract_t">Kreuninger JA, Cohen SL, Meurs EAIM, et al. Trends in readmission rate by route of hysterectomy - a single-center experience. Acta Obstet Gynecol Scand 2018; 97:285.</a></li><li><a class="nounderline abstract_t">Rajadurai VA, Tan J, Salfinger SG, Cohen PA. Outcomes in women undergoing robotic-assisted laparoscopic hysterectomy compared to conventional laparoscopic hysterectomy at a tertiary hospital in Western Australia. Aust N Z J Obstet Gynaecol 2018; 58:443.</a></li><li><a class="nounderline abstract_t">Lawrie TA, Liu H, Lu D, et al. Robot-assisted surgery in gynaecology. Cochrane Database Syst Rev 2019; 4:CD011422.</a></li><li><a class="nounderline abstract_t">Matsuo K, Mandelbaum RS, Nusbaum DJ, et al. Risk of Upper-body Adverse Events in Robot-assisted Total Laparoscopic Hysterectomy for Benign Gynecologic Disease. J Minim Invasive Gynecol 2021; 28:1585.</a></li><li><a class="nounderline abstract_t">American College of Obstetricians and Gynecologists’ Committee on Gynecologic Practice, The Society of Gynecologic Surgeons. Robot-Assisted Surgery for Noncancerous Gynecologic Conditions: ACOG COMMITTEE OPINION, Number 810. Obstet Gynecol 2020; 136:e22.</a></li><li><a class="nounderline abstract_t">Lim PC, Crane JT, English EJ, et al. Multicenter analysis comparing robotic, open, laparoscopic, and vaginal hysterectomies performed by high-volume surgeons for benign indications. Int J Gynaecol Obstet 2016; 133:359.</a></li><li><a class="nounderline abstract_t">Robot-Assisted Surgery for Noncancerous Gynecologic Conditions: ACOG COMMITTEE OPINION SUMMARY, Number 810. Obstet Gynecol 2020; 136:640.</a></li><li><a class="nounderline abstract_t">Baekelandt JF, De Mulder PA, Le Roy I, et al. Hysterectomy by transvaginal natural orifice transluminal endoscopic surgery versus laparoscopy as a day-care procedure: a randomised controlled trial. BJOG 2019; 126:105.</a></li><li><a class="nounderline abstract_t">Chen YJ, Wang PH, Ocampo EJ, et al. Single-port compared with conventional laparoscopic-assisted vaginal hysterectomy: a randomized controlled trial. Obstet Gynecol 2011; 117:906.</a></li><li><a class="nounderline abstract_t">Kovac SR, Barhan S, Lister M, et al. Guidelines for the selection of the route of hysterectomy: application in a resident clinic population. Am J Obstet Gynecol 2002; 187:1521.</a></li><li><a class="nounderline abstract_t">Kovac SR. Hysterectomy outcomes in patients with similar indications. Obstet Gynecol 2000; 95:787.</a></li><li><a class="nounderline abstract_t">Kovac SR. Decision-directed hysterectomy: a possible approach to improve medical and economic outcomes. Int J Gynaecol Obstet 2000; 71:159.</a></li><li><a class="nounderline abstract_t">Shiota M, Kotani Y, Umemoto M, et al. Indication for laparoscopically assisted vaginal hysterectomy. JSLS 2011; 15:343.</a></li><li><a class="nounderline abstract_t">Benassi L, Rossi T, Kaihura CT, et al. Abdominal or vaginal hysterectomy for enlarged uteri: a randomized clinical trial. Am J Obstet Gynecol 2002; 187:1561.</a></li><li><a class="nounderline abstract_t">Sailofsky S, Darin C, Alfahmy A, Sheyn D. Comparison of Surgical Outcomes After Total Laparoscopic Hysterectomy or Total Vaginal Hysterectomy for Large Uteri. Obstet Gynecol 2021; 137:445.</a></li><li><a class="nounderline abstract_t">Louie M, Strassle PD, Moulder JK, et al. Uterine weight and complications after abdominal, laparoscopic, and vaginal hysterectomy. Am J Obstet Gynecol 2018; 219:480.e1.</a></li><li><a class="nounderline abstract_t">Doucette RC, Sharp HT, Alder SC. Challenging generally accepted contraindications to vaginal hysterectomy. Am J Obstet Gynecol 2001; 184:1386.</a></li><li><a class="nounderline abstract_t">Tohic AL, Dhainaut C, Yazbeck C, et al. Hysterectomy for benign uterine pathology among women without previous vaginal delivery. Obstet Gynecol 2008; 111:829.</a></li><li><a class="nounderline abstract_t">Stovall TG, Ling FW, Crawford DA. Hysterectomy for chronic pelvic pain of presumed uterine etiology. Obstet Gynecol 1990; 75:676.</a></li><li><a class="nounderline abstract_t">Lindquist SAI, Shah N, Overgaard C, et al. Association of Previous Cesarean Delivery With Surgical Complications After a Hysterectomy Later in Life. JAMA Surg 2017; 152:1148.</a></li><li><a class="nounderline abstract_t">Delara R, Yi J, Girardo M, Wasson M. Perioperative Outcomes of Total Vaginal Hysterectomy in Women with Prior Cesarean Delivery. J Minim Invasive Gynecol 2020; 27:1603.</a></li><li><a class="nounderline abstract_t">Agostini A, Bretelle F, Cravello L, et al. Vaginal hysterectomy in nulliparous women without prolapse: a prospective comparative study. BJOG 2003; 110:515.</a></li><li><a class="nounderline abstract_t">Isik-Akbay EF, Harmanli OH, Panganamamula UR, et al. Hysterectomy in obese women: a comparison of abdominal and vaginal routes. Obstet Gynecol 2004; 104:710.</a></li><li><a class="nounderline abstract_t">Rafii A, Samain E, Levardon M, et al. Vaginal hysterectomy for benign disorders in obese women: a prospective study. BJOG 2005; 112:223.</a></li><li><a class="nounderline abstract_t">Rasmussen KL, Neumann G, Ljungström B, et al. The influence of body mass index on the prevalence of complications after vaginal and abdominal hysterectomy. Acta Obstet Gynecol Scand 2004; 83:85.</a></li><li><a class="nounderline abstract_t">Heinberg EM, Crawford BL 3rd, Weitzen SH, Bonilla DJ. Total laparoscopic hysterectomy in obese versus nonobese patients. Obstet Gynecol 2004; 103:674.</a></li><li><a class="nounderline abstract_t">Cosin JA, Brett Sutherland MA, Westgate CT, Fang H. Complications of Robotic Gynecologic Surgery in the Severely Morbidly Obese. Ann Surg Oncol 2016; 23:4035.</a></li><li><a class="nounderline abstract_t">Iavazzo C, Gkegkes ID. Robotic assisted hysterectomy in obese patients: a systematic review. Arch Gynecol Obstet 2016; 293:1169.</a></li><li><a class="nounderline abstract_t">Shah DK, Vitonis AF, Missmer SA. Association of body mass index and morbidity after abdominal, vaginal, and laparoscopic hysterectomy. Obstet Gynecol 2015; 125:589.</a></li><li><a class="nounderline abstract_t">ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention. Obstet Gynecol 2019; 133:e279.</a></li><li><a class="nounderline abstract_t">Agostini A, Vejux N, Bretelle F, et al. Value of laparoscopic assistance for vaginal hysterectomy with prophylactic bilateral oophorectomy. Am J Obstet Gynecol 2006; 194:351.</a></li><li><a class="nounderline abstract_t">Candiani M, Izzo S, Bulfoni A, et al. Laparoscopic vs vaginal hysterectomy for benign pathology. Am J Obstet Gynecol 2009; 200:368.e1.</a></li><li><a class="nounderline abstract_t">Jacoby VL, Vittinghoff E, Nakagawa S, et al. Factors associated with undergoing bilateral salpingo-oophorectomy at the time of hysterectomy for benign conditions. Obstet Gynecol 2009; 113:1259.</a></li><li class="breakAll">Hysterectomy Surveillance --- United States, 1994--1999 http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5105a1.htm (Accessed on November 25, 2014).</li><li><a class="nounderline abstract_t">Chichura AM, Yao M, Bretschneider CE, et al. Feasibility and Outcomes of Opportunistic Bilateral Salpingectomy in Patients with Traditional Relative Contraindications to Vaginal Hysterectomy. J Minim Invasive Gynecol 2020; 27:1405.</a></li><li><a class="nounderline abstract_t">Millet P, Gauthier T, Vieillefosse S, et al. Should we perform cervix removal during hysterectomy for benign uterine disease? Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF). J Gynecol Obstet Hum Reprod 2021; 50:102134.</a></li><li><a class="nounderline abstract_t">Lethaby A, Mukhopadhyay A, Naik R. Total versus subtotal hysterectomy for benign gynaecological conditions. Cochrane Database Syst Rev 2012; :CD004993.</a></li><li><a class="nounderline abstract_t">Andersen LL, Alling Møller LM, Gimbel HM. Objective comparison of subtotal vs. total abdominal hysterectomy regarding pelvic organ prolapse and urinary incontinence: a randomized controlled trial with 14-year follow-up. Eur J Obstet Gynecol Reprod Biol 2015; 193:40.</a></li><li><a class="nounderline abstract_t">Kim DH, Lee YS, Lee ES. Alteration of sexual function after classic intrafascial supracervical hysterectomy and total hysterectomy. J Am Assoc Gynecol Laparosc 2003; 10:60.</a></li><li><a class="nounderline abstract_t">Saini J, Kuczynski E, Gretz HF 3rd, Sills ES. Supracervical hysterectomy versus total abdominal hysterectomy: perceived effects on sexual function. BMC Womens Health 2002; 2:1.</a></li><li><a class="nounderline abstract_t">Brucker SY, Taran FA, Bogdanyova S, et al. Patient-reported quality-of-life and sexual-function outcomes after laparoscopic supracervical hysterectomy (LSH) versus total laparoscopic hysterectomy (TLH): a prospective, questionnaire-based follow-up study in 915 patients. Arch Gynecol Obstet 2014; 290:1141.</a></li><li><a class="nounderline abstract_t">Pouwels NSA, Brito LGO, Einarsson JI, et al. Cervix removal at the time of hysterectomy: factors affecting patients' choice and effect on subsequent sexual function. Eur J Obstet Gynecol Reprod Biol 2015; 195:67.</a></li><li><a class="nounderline abstract_t">Tsafrir Z, Aoun J, Papalekas E, et al. Risk factors for trachelectomy following supracervical hysterectomy. Acta Obstet Gynecol Scand 2017; 96:421.</a></li><li><a class="nounderline abstract_t">Ajao MO, Oliveira Brito LG, Wang KC, et al. Persistence of Symptoms After Total vs Supracervical Hysterectomy in Women with Histopathological Diagnosis of Adenomyosis. J Minim Invasive Gynecol 2019; 26:891.</a></li><li><a class="nounderline abstract_t">Yunker A, Curlin H, Banet N, et al. Does the uterine cervix become abnormally reinnervated after subtotal hysterectomy and what is the association with future trachelectomy? J Minim Invasive Gynecol 2015; 22:261.</a></li><li><a class="nounderline abstract_t">Schmitt JJ, Baker MV, Occhino JA, et al. Prospective Implementation and Evaluation of a Decision-Tree Algorithm for Route of Hysterectomy. Obstet Gynecol 2020; 135:761.</a></li><li><a class="nounderline abstract_t">Chrysostomou A, Djokovic D, Libhaber E, et al. Formal institutional guidelines promotes the vaginal approach to hysterectomy in patients with benign disease and non-prolapsed uterus. Eur J Obstet Gynecol Reprod Biol 2021; 259:133.</a></li><li><a class="nounderline abstract_t">Wallenstein MR, Ananth CV, Kim JH, et al. Effect of surgical volume on outcomes for laparoscopic hysterectomy for benign indications. Obstet Gynecol 2012; 119:709.</a></li><li><a class="nounderline abstract_t">Twijnstra AR, Blikkendaal MD, van Zwet EW, et al. Predictors of successful surgical outcome in laparoscopic hysterectomy. Obstet Gynecol 2012; 119:700.</a></li><li><a class="nounderline abstract_t">Vree FE, Cohen SL, Chavan N, Einarsson JI. The impact of surgeon volume on perioperative outcomes in hysterectomy. JSLS 2014; 18:174.</a></li><li><a class="nounderline abstract_t">Mehta A, Xu T, Hutfless S, et al. Patient, surgeon, and hospital disparities associated with benign hysterectomy approach and perioperative complications. Am J Obstet Gynecol 2017; 216:497.e1.</a></li><li><a class="nounderline abstract_t">Ruiz MP, Chen L, Hou JY, et al. Outcomes of Hysterectomy Performed by Very Low-Volume Surgeons. Obstet Gynecol 2018; 131:981.</a></li><li><a class="nounderline abstract_t">English EM, Bell S, Kamdar NS, et al. Importance of Estimated Blood Loss in Resource Utilization and Complications of Hysterectomy for Benign Indications. Obstet Gynecol 2019; 133:650.</a></li><li><a class="nounderline abstract_t">Dorsey JH, Holtz PM, Griffiths RI, et al. Costs and charges associated with three alternative techniques of hysterectomy. N Engl J Med 1996; 335:476.</a></li><li><a class="nounderline abstract_t">Sculpher M, Manca A, Abbott J, et al. Cost effectiveness analysis of laparoscopic hysterectomy compared with standard hysterectomy: results from a randomised trial. BMJ 2004; 328:134.</a></li><li><a class="nounderline abstract_t">Whiteside JL, Tumin D, Hohmann SF, Harris A. Determinants of Cost for Outpatient Hysterectomy for Benign Indications in a Nationwide Sample. Obstet Gynecol 2023; 141:765.</a></li><li><a class="nounderline abstract_t">Swenson CW, Kamdar NS, Harris JA, et al. Comparison of robotic and other minimally invasive routes of hysterectomy for benign indications. Am J Obstet Gynecol 2016; 215:650.e1.</a></li><li><a class="nounderline abstract_t">Falcone T, Paraiso MF, Mascha E. Prospective randomized clinical trial of laparoscopically assisted vaginal hysterectomy versus total abdominal hysterectomy. Am J Obstet Gynecol 1999; 180:955.</a></li><li><a class="nounderline abstract_t">Bijen CB, Vermeulen KM, Mourits MJ, de Bock GH. Costs and effects of abdominal versus laparoscopic hysterectomy: systematic review of controlled trials. PLoS One 2009; 4:e7340.</a></li><li><a class="nounderline abstract_t">Ross S, Lier D, Mackinnon G, et al. Can a simple 'cost-awareness' campaign for laparoscopic hysterectomy change the use and costs of disposable surgical supplies? Pre-post non-controlled study. BMJ Open 2019; 9:e027099.</a></li><li><a class="nounderline abstract_t">Lönnerfors C, Reynisson P, Persson J. A randomized trial comparing vaginal and laparoscopic hysterectomy vs robot-assisted hysterectomy. J Minim Invasive Gynecol 2015; 22:78.</a></li><li><a class="nounderline abstract_t">Tapper AM, Hannola M, Zeitlin R, et al. A systematic review and cost analysis of robot-assisted hysterectomy in malignant and benign conditions. Eur J Obstet Gynecol Reprod Biol 2014; 177:1.</a></li><li><a class="nounderline abstract_t">Broder MS, Kanouse DE, Mittman BS, Bernstein SJ. The appropriateness of recommendations for hysterectomy. Obstet Gynecol 2000; 95:199.</a></li></ol></div><div id="topicVersionRevision">Topic 3272 Version 77.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23635687" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Surgical management of leiomyomas for fertility or uterine preservation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21059487" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : AAGL position statement: route of hysterectomy to treat benign uterine disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26264829" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Surgical approach to hysterectomy for benign gynaecological disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28538495" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Committee Opinion No 701: Choosing the Route of Hysterectomy for Benign Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28538495" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Committee Opinion No 701: Choosing the Route of Hysterectomy for Benign Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32791126" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Trends in operative time and outcomes in minimally invasive hysterectomy from 2008 to 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27867051" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Total Laparoscopic Hysterectomy Versus Vaginal Hysterectomy: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29750957" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Characteristics associated with prolonged length of stay after hysterectomy for benign gynecologic conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29750957" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Characteristics associated with prolonged length of stay after hysterectomy for benign gynecologic conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29750957" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Characteristics associated with prolonged length of stay after hysterectomy for benign gynecologic conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33144242" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Robotic Vaginal Natural Orifice Transluminal Endoscopic Hysterectomy for Benign Indications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33838557" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Transvaginal natural orifice transluminal endoscopic versus conventional vaginal hysterectomy with uterosacral ligament suspension for apical compartment prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32891327" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) for omentectomy - A case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32715294" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Robotic transvaginal natural orifice transluminal endoscopic surgery for bilateral salpingo oophorectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30980991" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Transvaginal Natural Orifice Transluminal Endoscopic Hysterectomy and Apical Suspension of the Vaginal Cuff to the Uterosacral Ligament.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27880893" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Postoperative outcomes and quality of life following hysterectomy by natural orifice transluminal endoscopic surgery (NOTES) compared to laparoscopy in women with a non-prolapsed uterus and benign gynaecological disease: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Is Total Laparoscopic Hysterectomy with Longer Operative Time Associated with a Decreased Benefit Compared to total Abdominal Hysterectomy?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33039394" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Effect of length of surgery on the incidence of venous thromboembolism after benign hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31743796" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Vesicoureteral Injury during Benign Hysterectomy: Minimally Invasive Laparoscopic Surgery versus Laparotomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23395927" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : A randomized trial comparing conventional and robotically assisted total laparoscopic hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23423414" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20850391" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Comparing robot-assisted with conventional laparoscopic hysterectomy: impact on cost and clinical outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20949554" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Meta-analysis of observational studies on the safety and effectiveness of robotic gynaecological surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26272688" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Robotic Versus Laparoscopic Hysterectomy for Benign Disease: A Systematic Review and Meta-Analysis of Randomized Trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29192965" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Trends in readmission rate by route of hysterectomy - a single-center experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29168558" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Outcomes in women undergoing robotic-assisted laparoscopic hysterectomy compared to conventional laparoscopic hysterectomy at a tertiary hospital in Western Australia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30985921" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Robot-assisted surgery in gynaecology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33497727" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Risk of Upper-body Adverse Events in Robot-assisted Total Laparoscopic Hysterectomy for Benign Gynecologic Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32826597" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Robot-Assisted Surgery for Noncancerous Gynecologic Conditions: ACOG COMMITTEE OPINION, Number 810.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26952352" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Multicenter analysis comparing robotic, open, laparoscopic, and vaginal hysterectomies performed by high-volume surgeons for benign indications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32826595" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Robot-Assisted Surgery for Noncancerous Gynecologic Conditions: ACOG COMMITTEE OPINION SUMMARY, Number 810.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30325565" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Hysterectomy by transvaginal natural orifice transluminal endoscopic surgery versus laparoscopy as a day-care procedure: a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21422864" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Single-port compared with conventional laparoscopic-assisted vaginal hysterectomy: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12501056" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Guidelines for the selection of the route of hysterectomy: application in a resident clinic population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10831967" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Hysterectomy outcomes in patients with similar indications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11064014" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Decision-directed hysterectomy: a possible approach to improve medical and economic outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21985721" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Indication for laparoscopically assisted vaginal hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12501064" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Abdominal or vaginal hysterectomy for enlarged uteri: a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33543889" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Comparison of Surgical Outcomes After Total Laparoscopic Hysterectomy or Total Vaginal Hysterectomy for Large Uteri.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29959931" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Uterine weight and complications after abdominal, laparoscopic, and vaginal hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11408857" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Challenging generally accepted contraindications to vaginal hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18378741" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Hysterectomy for benign uterine pathology among women without previous vaginal delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2248635" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Hysterectomy for chronic pelvic pain of presumed uterine etiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28793157" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Association of Previous Cesarean Delivery With Surgical Complications After a Hysterectomy Later in Life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32156584" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Perioperative Outcomes of Total Vaginal Hysterectomy in Women with Prior Cesarean Delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12742338" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Vaginal hysterectomy in nulliparous women without prolapse: a prospective comparative study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15458890" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Hysterectomy in obese women: a comparison of abdominal and vaginal routes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15663588" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Vaginal hysterectomy for benign disorders in obese women: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14678090" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : The influence of body mass index on the prevalence of complications after vaginal and abdominal hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15051558" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Total laparoscopic hysterectomy in obese versus nonobese patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27334223" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Complications of Robotic Gynecologic Surgery in the Severely Morbidly Obese.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26861466" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Robotic assisted hysterectomy in obese patients: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25730220" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Association of body mass index and morbidity after abdominal, vaginal, and laparoscopic hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30913199" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16458628" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Value of laparoscopic assistance for vaginal hysterectomy with prophylactic bilateral oophorectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19136094" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Laparoscopic vs vaginal hysterectomy for benign pathology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19461420" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Factors associated with undergoing bilateral salpingo-oophorectomy at the time of hysterectomy for benign conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19461420" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Factors associated with undergoing bilateral salpingo-oophorectomy at the time of hysterectomy for benign conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31812614" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Feasibility and Outcomes of Opportunistic Bilateral Salpingectomy in Patients with Traditional Relative Contraindications to Vaginal Hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33794370" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Should we perform cervix removal during hysterectomy for benign uterine disease? Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22513925" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Total versus subtotal hysterectomy for benign gynaecological conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26231437" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Objective comparison of subtotal vs. total abdominal hysterectomy regarding pelvic organ prolapse and urinary incontinence: a randomized controlled trial with 14-year follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12554996" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Alteration of sexual function after classic intrafascial supracervical hysterectomy and total hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11825343" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Supracervical hysterectomy versus total abdominal hysterectomy: perceived effects on sexual function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24973868" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Patient-reported quality-of-life and sexual-function outcomes after laparoscopic supracervical hysterectomy (LSH) versus total laparoscopic hysterectomy (TLH): a prospective, questionnaire-based follow-up study in 915 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26479433" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Cervix removal at the time of hysterectomy: factors affecting patients' choice and effect on subsequent sexual function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28107774" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Risk factors for trachelectomy following supracervical hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30205164" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Persistence of Symptoms After Total vs Supracervical Hysterectomy in Women with Histopathological Diagnosis of Adenomyosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25460319" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Does the uterine cervix become abnormally reinnervated after subtotal hysterectomy and what is the association with future trachelectomy?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32168206" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Prospective Implementation and Evaluation of a Decision-Tree Algorithm for Route of Hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33662755" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Formal institutional guidelines promotes the vaginal approach to hysterectomy in patients with benign disease and non-prolapsed uterus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22433333" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Effect of surgical volume on outcomes for laparoscopic hysterectomy for benign indications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22395145" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Predictors of successful surgical outcome in laparoscopic hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24960479" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : The impact of surgeon volume on perioperative outcomes in hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28034651" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Patient, surgeon, and hospital disparities associated with benign hysterectomy approach and perioperative complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29742669" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Outcomes of Hysterectomy Performed by Very Low-Volume Surgeons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30870284" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Importance of Estimated Blood Loss in Resource Utilization and Complications of Hysterectomy for Benign Indications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8672153" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Costs and charges associated with three alternative techniques of hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14711748" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Cost effectiveness analysis of laparoscopic hysterectomy compared with standard hysterectomy: results from a randomised trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36897129" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Determinants of Cost for Outpatient Hysterectomy for Benign Indications in a Nationwide Sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27343568" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Comparison of robotic and other minimally invasive routes of hysterectomy for benign indications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10203664" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Prospective randomized clinical trial of laparoscopically assisted vaginal hysterectomy versus total abdominal hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19806210" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Costs and effects of abdominal versus laparoscopic hysterectomy: systematic review of controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31831528" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Can a simple 'cost-awareness' campaign for laparoscopic hysterectomy change the use and costs of disposable surgical supplies? Pre-post non-controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25045857" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : A randomized trial comparing vaginal and laparoscopic hysterectomy vs robot-assisted hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24703710" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : A systematic review and cost analysis of robot-assisted hysterectomy in malignant and benign conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10674580" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : The appropriateness of recommendations for hysterectomy.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
